TWD 14.45
(0.7%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 512.43 Million TWD | -22.4% |
2022 | 660.31 Million TWD | 41.02% |
2021 | 468.26 Million TWD | 2.87% |
2020 | 455.21 Million TWD | -3.53% |
2019 | 471.84 Million TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 503.01 Million TWD | -1.84% |
2024 Q2 | 503.01 Million TWD | 0.0% |
2023 Q4 | 512.43 Million TWD | 0.0% |
2023 FY | 512.43 Million TWD | -22.4% |
2023 Q3 | 512.43 Million TWD | -28.21% |
2023 Q2 | 713.76 Million TWD | 0.0% |
2023 Q1 | 713.76 Million TWD | 8.09% |
2022 FY | 660.31 Million TWD | 41.02% |
2022 Q4 | 660.31 Million TWD | 0.0% |
2022 Q3 | 660.31 Million TWD | 0.0% |
2021 FY | 468.26 Million TWD | 2.87% |
2020 FY | 455.21 Million TWD | -3.53% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 12.176% |
Level Biotechnology Inc. | 273.2 Million TWD | -87.568% |
Sagittarius Life Science Corp | 137.82 Million TWD | -271.805% |
NeoCore Technology Co., Ltd. | 197.47 Million TWD | -159.5% |
TaiMed Biologics Inc. | 1.32 Billion TWD | 61.408% |
GlycoNex Incorporation | 276.39 Million TWD | -85.398% |
VBI | 21.25 Million TWD | -2311.355% |
GeneReach Biotechnology Corp. | 313.7 Million TWD | -63.349% |
Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 0.43% |
Visgeneer Inc. | 185.6 Million TWD | -176.09% |
Mycenax Biotech Inc. | 1.32 Billion TWD | 61.273% |
Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 30.089% |
G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | -327.53% |
Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 77.185% |
TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -7643.079% |
Enimmune corporation | 173.46 Million TWD | -195.416% |
TaiRx, Inc. | 60.62 Million TWD | -745.257% |
CHO Pharma, Inc. | 110.83 Million TWD | -362.355% |
EirGenix Inc. | 1.14 Billion TWD | 55.249% |
BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | -357.611% |
Lin BioScience, Inc. | 167.73 Million TWD | -205.513% |
BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | -446.809% |
Feng Chi Biotech Corp. | 63.03 Million TWD | -712.953% |
Bio Preventive Medicine Corp. | 124.72 Million TWD | -310.84% |
Lukas Biomedical Inc. | 161.05 Million TWD | -218.167% |
RBC Bioscience Corporation | 513.08 Million TWD | 0.126% |
BiOptic Inc. | 170.56 Million TWD | -200.439% |
BRIM Biotechnology, Inc. | 42.15 Million TWD | -1115.515% |
Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -2103.556% |
Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -1811.151% |
Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 47.423% |
Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -7226.809% |
SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -2314.195% |
Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | -39.124% |
Neith Corporation | 17.43 Million TWD | -2839.465% |
Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -6327.96% |
NaviFUS Corp. | 53.4 Million TWD | -859.602% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | -6.428% |
Sinew Pharma Inc. | 39.71 Million TWD | -1190.318% |
Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -782.918% |
Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | -40.596% |
Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | -125.055% |
AP Biosciences Inc | 106.65 Million TWD | -380.485% |
Medigen Biotechnology Corp. | 3.53 Billion TWD | 85.484% |
3D Global Biotech Inc. | 30.68 Million TWD | -1570.21% |
Pharmosa Biopharm Inc. | 195.99 Million TWD | -161.461% |
Intech Biopharm Corporation | 1.54 Billion TWD | 66.794% |
Oneness Biotech Co., Ltd. | 866.42 Million TWD | 40.856% |
Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -5424.332% |
TWi Biotechnology, Inc. | 55.81 Million TWD | -818.132% |
Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | -119.969% |
TCI GENE Inc. | 155.54 Million TWD | -229.44% |
MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -1908.927% |
Senhwa Biosciences, Inc. | 46.17 Million TWD | -1009.772% |
Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | -56.007% |
NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -689.738% |
PharmaEngine, Inc. | 91 Million TWD | -463.08% |
Savior Lifetec Corporation | 457.95 Million TWD | -11.896% |
TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | -361.905% |
OBI Pharma, Inc. | 650.44 Million TWD | 21.218% |
Meribank Biotech Co., Ltd | 390.81 Million TWD | -31.121% |
Acepodia, Inc. | 384.47 Million TWD | -33.283% |
Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | -498.97% |